Aurinia Pharmaceuticals Inc. (AUPH) Current Reports & Earnings Releases
Upcoming
- 2026-11-03 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-19 | 8-K | Other Events | SEC |
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-04 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-11 | 8-K | Acquisition or Disposition, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-03 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-23 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-02-26 | 8-K | Results of Operations | SEC |
| 2025-11-04 | 8-K | Results of Operations | SEC |
| 2025-07-31 | 8-K | Results of Operations, Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-30 | 8-K | Other Events | SEC |
| 2025-05-15 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results | SEC |
| 2025-05-12 | 8-K | Results of Operations | SEC |
| 2025-02-27 | 8-K | Results of Operations | SEC |
| 2024-11-07 | 8-K | Results of Operations, Item 2.05, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-09-12 | 8-K | Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-02 | 8-K | Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2024-02-29 | 8-K | Officer / Director Changes | SEC |
| 2024-02-15 | 8-K | Results of Operations, Item 2.05, Other Events, Financial Statements & Exhibits | SEC |
| 2024-01-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.